Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05142332 · ClinicalTrials.gov registry record · NA
PROmotion of COvid-19 VA(X)Ccination in the Emergency Department - PROCOVAXED
A NA study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- NA
- Development phase
- 541
- Enrollment target
NCT05142332 is a NA study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 541 participants.
The verdict
NCT05142332, a NA study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- NA
- Development phase
- 541 participants
- Enrollment target
Study Summary
The goal of this research is to increase COVID-19 vaccine acceptance and uptake in vulnerable populations whose primary (and often only) health care access occurs in emergency departments (ED Usual Source of Care Patients). Toward this goal, the investigators will conduct one on one interviews and focus groups with ED Usual Source of Care Patients and community partners and produce trusted messaging informational platforms (PROmotion of COvid-19 VA(X)ccination in the Emergency Department - PROCOVAXED) that will address barriers to COVID-19 vaccination, especially vaccine hesitancy. The investigators will then conduct a cluster-randomized, controlled trial of PROCOVAXED platforms in six EDs to determine whether their implementation is associated with greater COVID-19 vaccine acceptance and uptake in ED Usual Source of Care Patients.
Interventions
- OTHER Covid-19 vaccine education materials
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 541 participants |
| Start Date | 2021-12-06 |
| Est. Completion | 2022-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05142332
The ClinicalTrials.gov registry entry for NCT05142332 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 541 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Covid-19 vaccine education materials is the first listed.
NCT05142332 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05142332 about?
NCT05142332 is a clinical study titled "PROmotion of COvid-19 VA(X)Ccination in the Emergency Department - PROCOVAXED". The goal of this research is to increase COVID-19 vaccine acceptance and uptake in vulnerable populations whose primary (and often only) health care access occurs in emergency departments (ED Usual Source of Care Patients). Toward this goal, the investigators will conduct one on one interviews and f...
What is the current status of trial NCT05142332?
This trial is currently terminated. It is a NA study. The enrollment target is 541 participants. The study started on 2021-12-06. Estimated completion is 2022-08-30.
What interventions are being tested in trial NCT05142332?
The interventions under investigation include: Covid-19 vaccine education materials (OTHER).
Who is sponsoring clinical trial NCT05142332?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.